Brief Research Report
Accepted on 04 Oct 2024
Low plasma levels of BTLA and LAG-3 before HCV therapy are associated with metabolic disorders after HCV eradication in persons with HIV/HCV coinfection: a retrospective study
in Pharmacology of Infectious Diseases